BRCA1 and BRCA2 genetic testing in hispanic patients: Mutation prevalence and evaluation of the BRCAPRO risk assessment model

Journal of Clinical Oncology

Volumn 25, Issue 29, 2007, Pages 4635-4641

  Vogel, Kristen J ^a   Atchley, Deann P ^a   Erlichman, Julie ^a   Broglio, Kristine R ^a   Ready, Kaylene J ^a   Valero, Vicente ^a   Amos, Christopher I ^a   Hortobagyi, Gabriel N ^a   Lu, Karen H ^a   Arun, Banu ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; CANCER MODEL; CANCER RISK; CANCER SUSCEPTIBILITY; COMPUTER PREDICTION; COMPUTER PROGRAM; DESCRIPTIVE RESEARCH; FAMILY HISTORY; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; HETEROZYGOSITY; HISPANIC; JEW; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PREVALENCE; RISK; ROC CURVE; UNITED STATES;

EID: 35648963187     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.4703     Document Type: Article

References (43)

1. Claus EB, Schildkraut JM, Thompson WD, et al: The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324, 1996
2. Malone KE, Daling JR, Neal C, et al: Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88:1393-1402, 2000
3. Pal T, Permuth-Wey J, Betts JA, et al: BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807-2816, 2005
4. Peto J, Collins N, Barfoot R, et al: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943-949, 1999
5. Risch HA, McLaughlin JR, Cole DE, et al: Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700-710, 2001
6. Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689, 1998
7. Narod SA, Ford D, Devilee P, et al: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families: Breast Cancer Linkage Consortium. Am J Hum Genet 56:254-264, 1995
8. Chen S, Iversen ES, Friebel T, et al: Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24:863-871, 2006
9. King MC, Marks JH, Mandell JB: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646, 2003
10. Díez O, Osorio A, Duran M, et al: Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301-312, 2003
11. Frank TS, Deffenbaugh AM, Reid JE, et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals. J Clin Oncol 20:1480-1490, 2002
12. Nanda R, Schumm LP, Cummings S, et al: Genetic testing in an ethnically diverse cohort of high-risk women: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925-1933, 2005
13. Shattuck-Eidens D, Oliphant A, McClure M, et al: BRCA1 sequence analysis in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing. JAMA 278:1242-1250, 1997
14. Barkardottir RB, Sarantaus L, Arason A, et al: Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families. Eur J Hum Genet 9:773-779, 2001
15. Baudi F, Quaresima B, Grandinetti C, et al: Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum Mutat 18:163-164, 2001
16. de la Hoya M, Osorio A, Godino J, et al: Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing. Int J Cancer 97:466-471, 2002
17. Díez O, Domenech M, Alonso MC, et al: Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population. Hum Genet 103:707-708, 1998
18. Liede A, Narod SA: Hereditary breast and ovarian cancer in Asia: Genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413-424, 2002
19. Pohlreich P, Zikan M, Stribrna J, et al: High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Breast Cancer Res 7:R728-R736, 2005
20. Ruiz-Flores P, Sinilnikova OM, Badzioch M, et al: BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico. Hum Mutat 20:474-475, 2002
21. Sarantaus L, Auranen A, Nevanlinna H: BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families. Int J Oncol 18:831-835, 2001
22. Sng JH, Ali AB, Lee SC, et al: BRCA1 c. 2845insA is a founder mutation in Singaporean Malay women with early onset breast/ovarian cancer. Ann Acad Med Singapore 32:S53-S55, 2003
23. 2004 National Healthcare Disparities Report, in DHHS (ed): Agency for Healthcare Research and Quality. Washington, DC, Department of Health and Human Services, 2004
24. Armstrong K, Weber B, Stopfer J, et al: Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk. Am J Med Genet A 117:154-160, 2003
25. Armstrong K, Micco E, Carney A, et al: Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293:1729-1736, 2005
26. McKean-Cowdin R, Spencer Feigelson H, Xia LY, et al: BRCA1 variants in a family study of African-American and Latina women. Hum Genet 116:497-506, 2005
27. Mullineaux LG, Castellano TM, Shaw J, et al: Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer 98:597-602, 2003
28. Weitzel JN, Lagos V, Blazer KR, et al: Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14:1666-1671, 2005
29. Barcenas CH, Hosain GM, Arun B, et al: Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24:354-360, 2006
30. Berry DA, Iversen ES Jr., Gudbjartsson DF, et al: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701-2712, 2002
31. Parmigiani G, Berry D, Aguilar O: Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62: 145-158, 1998
32. Reference deleted.
33. Sing T, Sander O, Beerenwinkel N, et al: ROCR: Visualizing classifier performance in R. Bioinformatics 21:3940-3941, 2005
34. Blesa JR, Garcia JA, Ochoa E: Frequency of germ-line BRCA1 mutations among Spanish families from a Mediterranean area. Hum Mutat 15:381-382, 2000
35. Osorio A, Robledo M, Martinez B, et al: Molecular analysis of the BRCA2 gene in 16 breast/ovarian cancer Spanish families. Clin Genet 54:142-147, 1998
36. Struewing JP, Abeliovich D, Peretz T, et al: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200, 1995
37. Berry DA, Parmigiani G, Sanchez J, et al: Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227-238, 1997
38. Euhus DM: Understanding mathematical models for breast cancer risk assessment and counseling. Breast J 7:224-232, 2001
39. Hall MJ, Olopade OI: Disparities in genetic testing: Thinking outside the BRCA box. J Clin Oncol 24:2197-2203, 2006
40. Euhus DM, Smith KC, Robinson L, et al: Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:844-851, 2002
41. Kopans DB, Rafferty E, Georgian-Smith D, et al: A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer 97:2951-2959, 2003
42. Parmigiani G, Chen S, Iversen E, et al: Validity of models for prediction of BRCA1 and BRCA2 mutations. Ann Intern Med (in press)
43. Howe HL, Wingo PA, Thun MJ, et al: Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93:824-842, 2001